Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphomaMark Kirschbaum, Paul Frankel, Leslie Popplewell, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2006
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expressionStephen Shibata, Warren Chow, Paul Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumabAnne M Schultheis, Georg Lurje, Katrin E Rhodes, et al.
International Journal of Cancer|December 4, 2010
A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistancePaul T Henderson, Tao Li, Miaoling He, et al.
Cancer Chemotherapy and Pharmacology|September 13, 2015
Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trialRobert J Morgan, Timothy W Synold, Jeffrey A Longmate, et al.
Seminars in Oncology|October 3, 2003
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working GroupJames H Doroshow, Timothy W Synold, David Gandara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancerReginald V N Lord, Jan Brabender, David Gandara, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium TrialYun Yen, Warren Chow, Lucille Leong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortiaAgustin A Garcia, Hal Hirte, Gini Fleming, et al.
The Journal of Liquid Biopsy|April 20, 2026
Harmonizing definitions in liquid biopsy: A terminology framework by the international society of liquid biopsyEloísa Jantus-Lewintre, Silvia Calabuig-Fariñas, David Gandara, et al.
Pageof 8